Last reviewed · How we verify
Antihypertensive algorithm — Competitive Intelligence Brief
phase 3
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Antihypertensive algorithm (Antihypertensive algorithm) — University Hospital, Tours. An algorithmic treatment protocol that guides sequential selection and titration of antihypertensive medications to achieve blood pressure control.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Antihypertensive algorithm TARGET | Antihypertensive algorithm | University Hospital, Tours | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Antihypertensive algorithm CI watch — RSS
- Antihypertensive algorithm CI watch — Atom
- Antihypertensive algorithm CI watch — JSON
- Antihypertensive algorithm alone — RSS
Cite this brief
Drug Landscape (2026). Antihypertensive algorithm — Competitive Intelligence Brief. https://druglandscape.com/ci/antihypertensive-algorithm. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab